{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:52:34Z","timestamp":1791280354478,"version":"4.1.0"},"reference-count":63,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To review the pharmacology, mycology, chemistry, pharmacokinetics, efficacy, safety, tolerability, dosage, administration, and economic issues of intravenous itraconazole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>A MEDLINE search from 1978 to June 2000 of the English-language literature and an extensive review of meeting abstracts was conducted. Due to the paucity of published information concerning the pharmacokinetics, efficacy, and safety of the intravenous formulation of intravenous itraconazole, additional information was obtained from the manufacturer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Data from in vitro and preclinical studies, as well as Phase II and III clinical trials, were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>The triazole antifungal agent itraconazole is available in a cyclodextrin-based intravenous formulation. Intravenous itraconazole is indicated for the treatment of pulmonary and extrapulmonary blastomycosis; histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis; and pulmonary and extrapulmonary aspergillosis in patients who are intolerant of or who are refractory to amphotericin B. This formulation provides quicker and more consistent therapeutic concentrations than the oral formulations. Clinical data comparing the efficacy of intravenous itraconazole with that of amphotericin B are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Intravenous itraconazole offers a less toxic alternative for patients with pulmonary and extrapulmonary blastomycosis, histoplasmosis, and aspergillosis who cannot receive oral medications or who are intolerant of or refractory to amphotericin B.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.10262","type":"journal-article","created":{"date-parts":[[2003,6,3]],"date-time":"2003-06-03T17:10:20Z","timestamp":1054660220000},"page":"720-729","source":"Crossref","is-referenced-by-count":54,"title":["Intravenous Itraconazole"],"prefix":"10.1177","volume":"35","author":[{"given":"Douglas","family":"Slain","sequence":"first","affiliation":[{"name":"Douglas Slain PharmD BCPS, Assistant Professor, Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, Morgantown, WV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P David","family":"Rogers","sequence":"additional","affiliation":[{"name":"P David Rogers PharmD MS, Assistant Professor, Department of Clinical Pharmacy Practice, School of Pharmacy; Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Mississippi, Jackson, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Cleary","sequence":"additional","affiliation":[{"name":"John D Cleary PharmD BCPS, Associate Professor, Department of Clinical Pharmacy Practice, School of Pharmacy; Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Mississippi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley W","family":"Chapman","sequence":"additional","affiliation":[{"name":"Stanley W Chapman MD, Professor, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Mississippi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2001,6,1]]},"reference":[{"key":"bibr1-aph.10262","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600411"},{"key":"bibr2-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60071-X"},{"key":"bibr3-aph.10262","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300407"},{"key":"bibr4-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.4.778"},{"key":"bibr5-aph.10262","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.6.477"},{"key":"bibr6-aph.10262","unstructured":"Kucers A, Crowe SM, Grayson ML, Hoy JF, eds. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs. 5th ed. Oxford: Butterworth-Heinemann, 1997:1418\u201344."},{"key":"bibr7-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.9.1310"},{"key":"bibr8-aph.10262","first-page":"163","volume":"51","author":"Poirier JM","year":"1996","journal-title":"Therapie"},{"key":"bibr9-aph.10262","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1992.tb05478.x"},{"key":"bibr10-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90127-N"},{"key":"bibr11-aph.10262","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.8.603.31529"},{"key":"bibr12-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1862"},{"key":"bibr13-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.660"},{"key":"bibr14-aph.10262","first-page":"88","volume-title":"Guide to clinically significant fungi","author":"Sutton DA","year":"1998"},{"key":"bibr15-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.3.321"},{"key":"bibr16-aph.10262","volume-title":"Sporanox (itraconazole) injection","year":"1999"},{"key":"bibr17-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.5"},{"key":"bibr18-aph.10262","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02290.x"},{"key":"bibr19-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2224"},{"key":"bibr20-aph.10262","first-page":"119","volume":"36","author":"Bossche H V","year":"1998","journal-title":"Med Mycol"},{"key":"bibr21-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"bibr22-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"bibr23-aph.10262","first-page":"231","volume":"43","author":"Brewster ME","year":"1989","journal-title":"J Parenter Sci Technol"},{"key":"bibr24-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.2.477"},{"key":"bibr25-aph.10262","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02296.x"},{"key":"bibr26-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)91178-X"},{"key":"bibr27-aph.10262","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015857902238"},{"key":"bibr28-aph.10262","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835060-00004"},{"key":"bibr29-aph.10262","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198937030-00003"},{"key":"bibr30-aph.10262","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1998.tb04465.x"},{"key":"bibr31-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.753"},{"key":"bibr32-aph.10262","doi-asserted-by":"publisher","DOI":"10.1159\/000040923"},{"key":"bibr33-aph.10262","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02299.x"},{"key":"bibr34-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_1.S94"},{"key":"bibr35-aph.10262","unstructured":"Glasmacher A, Hahn C, Molitor E, Sauerbruch T, Marklein G, Schmidt-Wolf IGH. Definition of a minimal effective trough concentration of itraconazole for antifungal prophylaxis in severely neutropenic patients with hematologic malignancies (abstract 1417). In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 26\u201329, 1999."},{"key":"bibr36-aph.10262","unstructured":"De Beule K, Jacqmin PH, Van Peer A, Stoffels P, Heykants J. The pharmacokinetics rationale behind intravenous itraconazole (abstract A75). In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 17\u201320, 1995."},{"key":"bibr37-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2714"},{"key":"bibr38-aph.10262","unstructured":"De Beule KL, Boogaerts M, Bow EJ, Garber G, Novitzky N, Winston D,  Pharmacokinetics of intravenous itraconazole and itraconazole oral solution given as empirical therapy for persistent fever in neutropenic patients with hematological malignancies (abstract 1193). In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 26\u201329, 1999."},{"key":"bibr39-aph.10262","unstructured":"Calliot D, Bassaris H, Seifert WF, Van de Velde V, Van der Geest R, Woestenborghs R,  Efficacy, safety and pharmacokinetics of intravenous followed by oral itraconazole in patients with invasive pulmonary aspergillosis (abstract 1646). In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 26\u201329, 1999."},{"key":"bibr40-aph.10262","unstructured":"Boogaerts M, Michaux JL, Bosly A, Van Hoof A, Jacqmin P, Van Peer A,  Pharmacokinetics and safety of seven days intravenous (I.V.) itraconazole (ITR) followed by two weeks oral ITR solution in patients with hematological malignancy (abstract A87). In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, New Orleans, September 15\u201318, 1996."},{"key":"bibr41-aph.10262","unstructured":"Plaisance K, Zhou H, Lee P, Hassell MS, Wu J, Travers S,  Pharmacokinetics of IV itraconazole (ITR) in subjects with varying degrees of renal function (abstract PII- 40). In: Abstracts of the 99th American Society for Clinical Pharmacology and Therapeutics, New Orleans, March 30\u2013April 1, 1998."},{"key":"bibr42-aph.10262","unstructured":"Taelman H, Boogaerts J, Kagame A, Batungwanayo J, Clerinx J, Vandeperre P. Randomized trial comparing itraconazole with amphotericin B in the primary therapy of AIDS associated cryptococcal meningitis (abstract WS-B12\u20133). Presented at the 9th International Conference on AIDS, Berlin, June 6\u201311, 1993."},{"key":"bibr43-aph.10262","doi-asserted-by":"publisher","DOI":"10.1086\/513943"},{"key":"bibr44-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90023-X"},{"key":"bibr45-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.1196"},{"key":"bibr46-aph.10262","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-3-345"},{"key":"bibr47-aph.10262","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.4.306.30934"},{"key":"bibr48-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90575-V"},{"key":"bibr49-aph.10262","doi-asserted-by":"publisher","DOI":"10.1086\/313750"},{"key":"bibr50-aph.10262","first-page":"86","volume":"39","year":"1997","journal-title":"Med Lett Drugs Ther"},{"key":"bibr51-aph.10262","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80311-8"},{"key":"bibr52-aph.10262","doi-asserted-by":"publisher","DOI":"10.1086\/313752"},{"key":"bibr53-aph.10262","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260202"},{"key":"bibr54-aph.10262","doi-asserted-by":"publisher","DOI":"10.1086\/515110"},{"key":"bibr55-aph.10262","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707033370103"},{"key":"bibr56-aph.10262","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.1.65"},{"key":"bibr57-aph.10262","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03118.x"},{"key":"bibr58-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2554"},{"key":"bibr59-aph.10262","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.404"},{"key":"bibr60-aph.10262","unstructured":"Glasmacher A, Molitor E, Hahn C, Sauerbruch T, Schmidt-Wolf IGH. Itraconazole trough levels in antifungal prophylaxis: comparison of six dosage regimens with capsules and solution (abstract J-143). In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 26\u201329, 1999."},{"key":"bibr61-aph.10262","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-2-199607150-00030"},{"key":"bibr62-aph.10262","unstructured":"Annemans L, Moeremans K, Milligan D, Kibbler C, Van Gool R. Economic evaluation of intravenous itraconazole in presumed systemic fungal infections (abstract 1867). In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Francisco, September 26\u201329, 1999."},{"key":"bibr63-aph.10262","volume-title":"2000 Drug topics red book","author":"Cardinale V","year":"2000"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.10262","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.10262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:48Z","timestamp":1777374288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.10262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":63,"aliases":["10.1345\/1542-6270(2001)035<0720:ii>2.0.co;2"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1345\/aph.10262"],"URL":"https:\/\/doi.org\/10.1345\/aph.10262","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}